Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$81.88

-0.17 (-0.21%)

17:19
06/18/17
06/18
17:19
06/18/17
17:19

Eli Lilly granted Orphan designation for pediatric colitis treatment

The FDA has granted Eli Lilly Orphan designation for its "humanized immunoglobulin G4-variant monoclonal antibody directed against the p19 subunit of interleukin-23" product in the treatment of ulcerative colitis in pediatric patients. The designation was granted June 15. Reference Link

LLY Eli Lilly
$81.88

-0.17 (-0.21%)

06/14/17
RHCO
06/14/17
NO CHANGE
RHCO
Eli Lilly has positive read through from J&J data, says SunTrust
SunTrust analyst John Boris says that data for Johnson & Johnson's (JNJ) Invokana for diabetes represented a best-case scenario for Eli Lilly (LLY). J&J's drug "significantly reduced the combined risk of cardiovascular death, myocardial infarction and nonfatal stroke in diabetes patients at risk for or with a history of CV diseases," and its efficacy on CV death is positive for the SGLT-2 class, to which Eli Lilly's Jardiance also belongs, according to the analyst. But the data leaves Jardiance, which reduced CV death by a statistically significant 38% versus Invokana's non-significant 13%, as the best in the class, wrote the analyst, who reiterates a $101 price target and a Buy rating on Eli Lilly.
06/12/17
LEER
06/12/17
NO CHANGE
Target $90
LEER
Outperform
Eli Lilly price target lowered to $90 from $93 at Leerink
Leerink analyst Seamus Fernandez lowered his price target for Eli Lilly (LLY) to $90 to reflect reduced sales forecasts for baricitinib, an oral JAK1/2 inhibitor to treat rheumatoid arthritis which the company collaborates with Incyte (INCY). Following AbbVie's (ABBV) positive Phase 3 data last week for its JAK1 inhibitor upadacitinib, Fernandez dropped his U.S. peak sales estimate for baricitinib by more than 50% to $400M and pushed out his U.S. launch time to 2020 from 2018. The analyst keeps an Outperform rating on Lilly shares.
06/07/17
FBCO
06/07/17
NO CHANGE
Target $38
FBCO
Outperform
ASCO meeting highlights pressure on Pfizer cancer assets, says Credit Suisse
Credit Suisse analyst Vamil Divan said he came away from the ASCO meeting feeling like positive progress by competitors is increasing the pressure on Pfizer's (PFE) cancer assets, specifically pointing to positive data for Roche's (RHHBY) Alecensa, Johnson & Johnson's (JNJ) Zytiga and Eli Lilly's (LLY) abemaciclib. Additionally, competition in the immune-oncology and PARP spaces will make it more challenging for Pfizer to gain traction, added Divan. He keeps an Outperform rating on Pfizer, citing valuation and its dividend yield, but he has concerns about its upcoming patent expirations and growth products.
06/06/17
WELS
06/06/17
NO CHANGE
WELS
Amazon may be the next threat to drug pricing, says Wells Fargo
After CNBC recently reported that Amazon (AMZN) is considering going into the prescription pharmacy business in the U.S., Wells Fargo surveyed nearly 2,900 U.S. adults and found that 54% of those polled said they would use or would probably use "Amazon Pharmacy." While the e-commerce giant has not confirmed its U.S. pharmacy interest, if it did enter the market analyst David Maris believes it could see fast adoption and "usher in a new age of price transparency." Maris also wonders if pharmacy "may be just the beginning" and if Amazon eyes the "even larger prize" of fully integrated digital healthcare. Publicly traded large-cap pharmaceuticals companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded retail pharmacy operators include CVS Health (CVS), Walgreens (WBA), Fred's (FRED) and Rite Aid (RAD).

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
01/16/19
01/16
11:17
01/16/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
01/16/19
01/16
11:16
01/16/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CF

CF Industries

$42.03

-1.26 (-2.91%)

11:15
01/16/19
01/16
11:15
01/16/19
11:15
Options
CF Industries put volume heavy and directionally bearish »

Bearish flow noted in CF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

11:15
01/16/19
01/16
11:15
01/16/19
11:15
General news
U.S. VIX equity volatility rose 1.8% to probe 19.0 »

U.S. VIX equity…

SIG

Signet Jewelers

$33.76

-0.05 (-0.15%)

11:14
01/16/19
01/16
11:14
01/16/19
11:14
Hot Stocks
Signet Jewelers says to pay total of $11M to CFPB, NYS in investigations »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$98.39

-2.03 (-2.02%)

11:13
01/16/19
01/16
11:13
01/16/19
11:13
Rumors
Rumor moving shares of Twilio »

Rumor: Twilio moves off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 12

    Feb

11:10
01/16/19
01/16
11:10
01/16/19
11:10
General news
Treasury Action: curve steepening has been the general trend this year »

Treasury Action: curve…

SQ

Square

$66.03

0.13 (0.20%)

, FISV

Fiserv

$70.17

-4.84 (-6.45%)

11:09
01/16/19
01/16
11:09
01/16/19
11:09
Recommendations
Square, Fiserv, First Data analyst commentary  »

Fiserv deal for First…

SQ

Square

$66.03

0.13 (0.20%)

FISV

Fiserv

$70.17

-4.84 (-6.45%)

FDC

First Data

$20.72

3.17 (18.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

11:05
01/16/19
01/16
11:05
01/16/19
11:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

YELP

Yelp

$35.64

0.67 (1.92%)

11:03
01/16/19
01/16
11:03
01/16/19
11:03
Hot Stocks
Breaking Hot Stocks news story on Yelp »

Yelp says to review…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$35.65

0.68 (1.94%)

11:03
01/16/19
01/16
11:03
01/16/19
11:03
Hot Stocks
Breaking Hot Stocks news story on Yelp »

Yelp says 'willing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$35.65

0.68 (1.94%)

11:03
01/16/19
01/16
11:03
01/16/19
11:03
Hot Stocks
Yelp says 'open to hearing ideas and investor input, including from SQN' »

Yelp issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$43.85

-3.41 (-7.22%)

11:02
01/16/19
01/16
11:02
01/16/19
11:02
Downgrade
Nordstrom rating change  »

Nordstrom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

KEYS

Keysight Technologies

$68.05

-0.47 (-0.69%)

11:01
01/16/19
01/16
11:01
01/16/19
11:01
Hot Stocks
Keysight Technologies, others sign agreement with UNISOC »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDSI

BioDelivery Sciences

$4.24

0.08 (1.92%)

11:00
01/16/19
01/16
11:00
01/16/19
11:00
Options
Call buyer in BioDelivery Sciences International as the rally continues »

Call buyer in BioDelivery…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
01/16/19
01/16
11:00
01/16/19
11:00
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

JPM

JPMorgan

$102.15

0.45 (0.44%)

10:55
01/16/19
01/16
10:55
01/16/19
10:55
Conference/Events
Economic Club of New York to hold a luncheon meeting »

JPMorgan Chairman &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 26

    Feb

APA

Apache

$31.93

0.17 (0.54%)

10:50
01/16/19
01/16
10:50
01/16/19
10:50
Options
Aggressive option play opened in Apache as shares extend gains »

Aggressive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

EA

Electronic Arts

$86.34

-3.14 (-3.51%)

, ATVI

Activision Blizzard

$45.89

-0.92 (-1.97%)

10:48
01/16/19
01/16
10:48
01/16/19
10:48
Recommendations
Electronic Arts, Activision Blizzard analyst commentary  »

Stephens a buyer of…

EA

Electronic Arts

$86.34

-3.14 (-3.51%)

ATVI

Activision Blizzard

$45.89

-0.92 (-1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 12

    Feb

  • 25

    Feb

UAL

United Continental

$86.50

5.27 (6.49%)

10:48
01/16/19
01/16
10:48
01/16/19
10:48
Hot Stocks
United Continental 'paying close attention to government shutdown' »

CEO Oscar Munoz says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 04

    Mar

DB

Deutsche Bank

$9.01

0.39 (4.52%)

10:42
01/16/19
01/16
10:42
01/16/19
10:42
Periodicals
Deutsche Bank regulators said to favor European merger, Bloomberg says »

The ECB is said to favor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,088.98

12.07 (1.12%)

, GOOGL

Alphabet Class A

$1,098.50

12.14 (1.12%)

10:42
01/16/19
01/16
10:42
01/16/19
10:42
Hot Stocks
Google's YouTube banning 'dangerous challenges and pranks' »

In an update to their…

GOOG

Alphabet

$1,088.98

12.07 (1.12%)

GOOGL

Alphabet Class A

$1,098.50

12.14 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

SM

SM Energy

$20.07

0.24 (1.21%)

10:40
01/16/19
01/16
10:40
01/16/19
10:40
Options
Bullish option flow in SM Energy after analyst action »

Bullish option flow in SM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$17.22

-1.1 (-6.00%)

10:35
01/16/19
01/16
10:35
01/16/19
10:35
Recommendations
Adient analyst commentary  »

Adient shares to remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 07

    Feb

10:35
01/16/19
01/16
10:35
01/16/19
10:35
General news
Today's U.S. NAHB Bounce to 58 »

Today's U.S. NAHB…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.